Tanya Lugani, M. Nagpal, D. S. Malik, Ameya Sharma, V. Puri, G. Dhingra
{"title":"Nanocarriers as Prospective Approach in Effective Management of Acne Vulgaris","authors":"Tanya Lugani, M. Nagpal, D. S. Malik, Ameya Sharma, V. Puri, G. Dhingra","doi":"10.2174/1876402912999200917112151","DOIUrl":null,"url":null,"abstract":"\n\nAcne is a chronic disease associated with the pilosebaceous unit and is affected by Propionibacterium\nacnes bacteria. Approximately 95% of people worldwide suffer from acne in their life span\nwith a higher prevalence among teenagers (esp. boys). Conventional strategies incorporating antibiotics,\nsteroids, hormones, etc. are recommended orally, systemically, or topically, employed for the treatment\nof acne but with various side effects (itching, scaling, redness, etc.) and are no more commercially accepted.\nThe literature has been collected using various search engines google scholar, PubMed, science\ndirect, etc. The review highlights the history of acne, its pathophysiology, developmental factors, various\ntreatment evolutions strategies ranging from conventional to novel approach eradicating the secondary\neffects with enhanced efficacy and safety profile. We discussed various nanotechnological carriers\n(liposomes, niosomes, solid lipid nanoparticles, nanostructured lipid carriers, microsponges and other\nnanoscale formulations), which are formulated in the last decade for the effective treatment of acne. Patent\nliterature and marketed formulations are included in the last sections. The encapsulation efficiency\nof anti-acne drugs in different nanocarriers improves the efficacy as well as minimizes the side effects\nof the drug. These carriers showed better bioavailability as well as better penetration effects even to the\npilosebaceous unit of the skin. Tolerance can be improved by increasing the concentration of anti-acne\ndrugs in the nano-carrier formulation. Conventional treatment strategies for acne had some limitations\nlike scaling, itching, and inflammation which can be overcome by nano-formulations, which exhibit better\nefficacy. At present, various nano-technological carriers are being used potentially for the treatment\nof acne. These nano-formulations are also associated with some limitations like drug entrapment, stability\nissues, but these will be overcome in the upcoming years as long as the research is being continued\nin this area.\n","PeriodicalId":18543,"journal":{"name":"Micro and Nanosystems","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Micro and Nanosystems","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1876402912999200917112151","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Engineering","Score":null,"Total":0}
引用次数: 0
Abstract
Acne is a chronic disease associated with the pilosebaceous unit and is affected by Propionibacterium
acnes bacteria. Approximately 95% of people worldwide suffer from acne in their life span
with a higher prevalence among teenagers (esp. boys). Conventional strategies incorporating antibiotics,
steroids, hormones, etc. are recommended orally, systemically, or topically, employed for the treatment
of acne but with various side effects (itching, scaling, redness, etc.) and are no more commercially accepted.
The literature has been collected using various search engines google scholar, PubMed, science
direct, etc. The review highlights the history of acne, its pathophysiology, developmental factors, various
treatment evolutions strategies ranging from conventional to novel approach eradicating the secondary
effects with enhanced efficacy and safety profile. We discussed various nanotechnological carriers
(liposomes, niosomes, solid lipid nanoparticles, nanostructured lipid carriers, microsponges and other
nanoscale formulations), which are formulated in the last decade for the effective treatment of acne. Patent
literature and marketed formulations are included in the last sections. The encapsulation efficiency
of anti-acne drugs in different nanocarriers improves the efficacy as well as minimizes the side effects
of the drug. These carriers showed better bioavailability as well as better penetration effects even to the
pilosebaceous unit of the skin. Tolerance can be improved by increasing the concentration of anti-acne
drugs in the nano-carrier formulation. Conventional treatment strategies for acne had some limitations
like scaling, itching, and inflammation which can be overcome by nano-formulations, which exhibit better
efficacy. At present, various nano-technological carriers are being used potentially for the treatment
of acne. These nano-formulations are also associated with some limitations like drug entrapment, stability
issues, but these will be overcome in the upcoming years as long as the research is being continued
in this area.